Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02314832 · ClinicalTrials.gov registry record · NA
Risk of Falling After CFNB Versus ACB
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02314832: Completed NA study, sponsored by University of Pennsylvania.
NCT02314832 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02314832, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
Blocking sensation from the femoral nerve by injecting local anesthetic around the nerve plays an important role in pain control after total knee replacement. However, femoral nerve block has been associated with increased risk of falls due to weakness of the thigh muscle. This prospective, randomized controlled trial asks the question whether blocking the more distal branch of the femoral nerve (saphenous nerve) will result in less muscle motor block, and thus less risk of falls. The study also aims to compare pain control after both techniques.
Interventions
- PROCEDURE adductor canal block
- PROCEDURE femoral nerve block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02314832
The ClinicalTrials.gov registry entry for NCT02314832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which adductor canal block is the first listed.
NCT02314832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02314832 about?
NCT02314832 is a clinical study titled "Risk of Falling After CFNB Versus ACB". Blocking sensation from the femoral nerve by injecting local anesthetic around the nerve plays an important role in pain control after total knee replacement. However, femoral nerve block has been associated with increased risk of falls due to weakness of the thigh muscle. This prospective, randomiz...
What is the current status of trial NCT02314832?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-09. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02314832?
The interventions under investigation include: adductor canal block (PROCEDURE), femoral nerve block (PROCEDURE).
Who is sponsoring clinical trial NCT02314832?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.